Blog
Ask the Experts: How has HIV Testing and Awareness Progressed?
Today, there are many treatments and preventions available for HIV. Data reveals that, across the US, there has been a 39% increase in the use of…
Featured Insights
Ask the Experts: Understanding Juvenile Idiopathic Arthritis
In light of JIA Awareness Month, its treatments, its stigma, and more, we spoke with Dr. Johnny Peppers, Executive Director of Drug Development for…
PRA Teams with Microsoft to Enhance COVID-19 Monitoring
Over the past several months, participants in PRA Health Sciences’ Health Harmony COVID-19 Monitoring Program have had vital information about…
All Insights
Blog
Newsletter
Direct to Patient Delivery of Investigational Product
As a result of the COVID-19 pandemic travel restrictions of varying degrees have been imposed in most countries, consequently patients are not able…
Newsletter
The Future is Here
You will have all read, with great excitement, the articles about the mobile and decentralized clinical study that PRA and Janssen have partnered on…
Newsletter
Country Considerations for Remote Monitoring and Remote Source Data Verification
Whilst COVID-19 has affected / is still affecting all our day to day lives we need to remember the greatest impact has been and still is in hospitals…
Newsletter
Virtual Trials: Benefits & Challenges
Compared to traditional study models, the strength of the virtual trials concept is the ability to make it easier to include patients from diverse…
Newsletter
Virtual Trials and the Regulatory Puzzle
Where is that one guideline providing all regulatory considerations for virtual trials? The one document that clearly describes all requirements…
White Paper
Pediatric Product Development Plan
Development of the Pediatric Study Plan (PSP) for the United States Food and Drug Administration and the Pediatric Investigation Plan (PIP) for the…
Case Study
Early Phase Innovative Pediatric Oncology Program Achieves Successful First Multiple Solid Tumors Study
PRA partnered with the sponsor’s new pediatric oncology department on an innovative pediatric oncology program. The program provided early evaluation…
Newsletter
Industry Watch
The third week of June brings news of the first, much-anticipated breakthrough in the treatment of COVID-19. Scientists from the UK have discovered…
Blog
The RACE for Children Act
In the US, legislation such as the Better Pharmaceuticals for Children Act (BPCA) and the Pediatric Research Equity Act (PREA) have helped to…